Norway has one of the highest rates of death due to prostate cancer (PCa) in the world. To assess the contribution of both common and rare single nucleotide variants (SNPs) to the prostate cancer burden in Norway, we assessed the frequency of the established prostate cancer susceptibility allele, HOXB13 G84E, as well as a series of validated, common PCa risk SNPs in a Norwegian PCa population of 779 patients. The G84E allele was observed in 2.3% of patients compared to 0.7% of control individuals, OR = 3.8, P = 1 × 10-4. While there was a trend toward an earlier age at diagnosis, overall the clinicopathologic features of PCa were not significantly different in G84E carriers and non-carriers. Evaluation of 32 established common risk alleles revealed significant associations of risk alleles at 13 loci, including SNPs at 8q24, and near TET2, SLC22A3, NKX3-1, CASC8, MYC, DAP2IP, MSMB, HNF1B, PPP1R14A, and KLK2/3. When the data for each SNP are combined into a genetic risk score (GRS), Norwegian men within the top decile of GRS have over 5-fold greater risk to be diagnosed with PCa than men with GRS in the lowest decile. These results indicate that risk alleles of HOXB13 and common variant SNPs are important components of inherited PCa risk in the Norwegian population, although these factors appear to contribute little to the malignancy's aggressiveness. 
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| SNP genotyping and HOXB13 sequencing
A total of 32 SNPs known to be associated with risk of being diagnosed with PCa were assessed in this study. Genotyping in cases was performed as previously described using mass spectrometry. 5, 12 To compare allele frequencies between Norwegian PCa patients and Norwegian population, array data from n = 4700 Norwegian blood donors were used. Genomic DNA from these individuals was extracted from peripheral whole blood, and genotyped at deCODE Genetics The complete open reading frame for HOXB13 was sequenced using Sanger Sequencing as described (ref 6) . Correlation between sequence data obtained using Sanger sequencing and Taqman technology, as previously described ref 6, was 100%.
| Genetic risk assessment and statistical analysis
Genetic risk assessment was used for the evaluation of individual disease risk. Risk alleles (R) and non-risk alleles (N) were counted at each locus. Genotype RR was counted as 2, RN as 1, and NN as 0. Then, the number of risk alleles was summed. Student's t-tests (for normal variables) and Mann-Whitney U-tests (for non-normal variables) were used to compare the variables among groups in univariate analyses. In multivariate analyses, logistic regression was used to evaluate the three genetic risk assessment methods after adjusting for clinical variables. All statistical analyses were performed using SPSS 22.0 (IBM Corporation, New York). Twotailed P < 0.05 was considered statistically significant.
3 | RESULTS
| HOXB13
To search for coding sequence variants including possible novel founder mutations in the Norwegian population, we sequenced the complete coding region of the HOXB13 gene in 779 PCa cases. As summarized in Table 1 , over half (52.8%) of these cases had cancers with clinical Gleason Score 7 or higher. In total, we found 18 carriers of the G84E HOXB13 mutation, for a carrier frequency of 2.3%. This rate compares to 0.7% carrier rate observed in 1643 anonymous blood donors. The OR for PCa in G84E carriers in the Norwegian population is 3.8, P = 0.001 (Table 2 ).
An evaluation of the clinicopathologic tumor characteristics in the G84E carriers showed that these cancers were similar to cancers seen in non-carriers. While there is a trend towards younger age at diagnosis in G84E carriers undergoing radical surgery for PCa (60.5 years for G84E carriers vs 62.6 years for non-carriers), the frequency with low grade disease (2.25%), suggesting that G84E does not predispose men to higher grade prostate cancer in the Norwegian population.
Other than the G84E variant, we found no other non-synonymous coding sequence mutations. The only other variants observed were two previously observed synonymous polymorphisms at Serine codons 122 and 127 (rs8556 and rs9900627, respectively).
| PCa risk SNPs
We genotyped a set of 32 validated PCa risk SNPs 12, 13 in the same set of 779 PCa cases. These data are presented in Table 3 . Of the 29 evaluable SNPs (no control data are available for three SNPs), 13
showed a statistically significant association with PCa risk. With several exceptions, the remaining SNPs showed frequency differences in the same direction as previously reported, 12 thus, it is likely that the relatively small sample size accounts for the lack of significance of many of these SNPs. Significant associations By combining SNP data, a genetic risk score (GRS) was calculated based on the number of risk alleles an individual inherits. 5, 13, 14 PCa risk as a function of GRS in the Norwegian | 189 population was examined in Table 4 . The median GRS for cases was significantly higher than that calculated for the control population (P = 4.98E-27). An analysis of risk by decile of GRS indicates an ability to stratify risk over a fivefold range, with individuals with the highest and lowest decile of GRS having a 2.5 and 0.5 fold risk of PCa, respectively, when compared to the average population risk.
There was no difference in the GRS in carriers vs non-carriers of HOXB13 G84E, indicating the independent effects of these alleles on PCa risk. Furthermore, GRS had no effect on risk of PCa death, although the number of events was low.
| DISCUSSION
In a Norwegian population of men with PCa, we find that both HOXB13 G84E and at least 13 PCa risk SNPs are associated with risk for PCa.
The significant association of HOXB13 G84E with PCa risk in the Norwegian population extends the number of study populations where such an association has been observed. While the G84E variant and some of the larger effect SNPs are present at higher frequencies than in European American study populations, the lack of association of these SNPs with clinical parameters suggests that these genetic 
